Drug Search Results
More Filters [+]

L-serine

Alternative Names: l-serine
Latest Update: 2024-12-10
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Subcutaneous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bosnia | Brazil | Croatia | India | Ireland | Taiwan | Thailand | Turkey | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: M.D. Anderson Cancer Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for L-serine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Other

Phase 2: Amyotrophic Lateral Sclerosis|Alzheimer Disease|Peripheral Nervous System Diseases|Hereditary Sensory and Autonomic Neuropathies

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2400089707

N/A

Not yet recruiting

Kidney Diseases

2026-01-01

SENSE

P2

Recruiting

Hereditary Sensory and Autonomic Neuropathies

2025-08-01

2022-000241-32

P3

Active, not recruiting

Other

2025-06-30

FATHIS+

N/A

Recruiting

Non-alcoholic Fatty Liver Disease|Fatty Liver, Alcoholic|Liver Diseases, Alcoholic|Obesity, Abdominal

2025-05-01

Recent News Events